Terns Pharmaceuticals, Inc. (TERN) Share-based Payment Arrangement, Expense USD 2020 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Terns Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2020 to 2024.
  • Terns Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $4.03 M, a 2.29% increase year-over-year.
  • Terns Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2024 was $25.6 M, a 114% increase year-over-year.
  • Terns Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $25.5 M, a 137% increase from 2022.
  • Terns Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $10.8 M, a 32.2% increase from 2021.
  • Terns Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $8.15 M, a 382% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $25.6 M $4.03 M +$90 K +2.29% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $25.5 M $3.28 M +$595 K +22.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-14
Q3 2023 $24.9 M $14.1 M +$11.4 M +424% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $13.5 M $4.23 M +$1.58 M +59.7% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $12 M $3.94 M +$1.19 M +43.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 $10.8 M $2.69 M +$137 K +5.37% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-14
Q3 2022 $10.6 M $2.69 M +$831 K +44.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $9.8 M $2.65 M +$742 K +38.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $9.06 M $2.74 M +$912 K +49.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $8.15 M $2.55 M +$1.76 M +224% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-27
Q3 2021 $6.38 M $1.86 M +$1.34 M +262% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $5.04 M $1.91 M +$1.72 M +905% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $3.32 M $1.83 M +$1.63 M +807% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $1.69 M $786 K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-07
Q3 2020 $513 K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $190 K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $202 K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.